Personal information

Activities

Collapse all

Funding (9)

Development of novel therapeutic strategies for treatment-refractory AML

2020-04 to 2025-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER:

20H05699
Source: Self-asserted source
Takahiro Maeda

Development of novel differentiation therapies for acute myeloid leukemia

2018-06 to 2020-03 | Grant
Japan Agency for Medical Research and Development (Tokyo, JP)
GRANT_NUMBER:

18cm0106135h0001
Source: Self-asserted source
Takahiro Maeda

Genome-wide CRISPR/Cas9 screening to identify novel therapeutic targets for AML

2017-04 to 2020-03 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER:

17H01567
Source: Self-asserted source
Takahiro Maeda

Targeting the NuRD complex for fetal globin induction

2016-09 to 2021-08 | Grant
National Institutes of Health (MD, MD, US)
GRANT_NUMBER:

R01DK111455
Source: Self-asserted source
Takahiro Maeda

ASH Bridge Grant

2015-10 to 2016-09 | Grant
American Society of Hematology (DC, DC, US)
Source: Self-asserted source
Takahiro Maeda

Targeting the transcription machinery for fetal globin induction

2015-10 to 2016-09 | Grant
National Institutes of Health (MD, MD, US)
GRANT_NUMBER:

1R56DK105001
Source: Self-asserted source
Takahiro Maeda
grade
Preferred source (of 2)‎

Targeting endocytic adaptor proteins in leukemia

2013-10 to 2017-09 | Grant
American Cancer Society (GA, GA, US)
GRANT_NUMBER:

RSG-13-379-01-LIB
Source: Self-asserted source
Takahiro Maeda

Regulation of B cell development by the proto-oncogene LRF/Pokemon

2010-10 to 2015-09 | Grant
National Institutes of Health (MD, MD, US)
GRANT_NUMBER:

1R01AI084905
Source: Self-asserted source
Takahiro Maeda

Role of the Proto-oncogene LRF in Normal B Cell Development and Lymphomagenesis

2008-01 to 2010-12 | Award
American Society of Hematology (DC, DC, US)
Source: Self-asserted source
Takahiro Maeda
How many people are using ORCID?